Company / Income Tax
Emergent BioSolutions Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$30.2M
FY2025
5-year range
-$7.4M / $83.7M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
#31 of 204
Health Care
What the data says
Emergent BioSolutions Inc.'s income tax of $30M is higher than 85% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$7M in FY2022 to $102M in FY2020.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of -21.6%. Top quartile in the Health Care sector.
Increased from $29M to $30M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -21.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 204This company $30.2M Sector average $118.7M
▼
-74.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -21.6%, indicating a declining trend.
- In FY2025, income tax decreased 36.7% year-over-year.
- Ranks #31 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.2M | -36.7% |
| FY2024 | $47.7M | +62.8% |
| FY2023 | $29.3M | +495.9% |
| FY2022 | -$7.4M | -108.8% |
| FY2021 | $83.7M | -18.0% |
| FY2020 | $102.1M | +345.9% |
| FY2019 | $22.9M | -37.6% |
| FY2018 | $36.7M | +1.9% |
| FY2017 | $36.0M | -1.9% |
| FY2016 | $36.7M | -17.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026